Early Access — free while we kick the tires
EdgarHawk

Garis Douglas Michael

EVP&CFO

Officer
5 filings analyzed · 1 company · Latest 2026-03-16

Companies

Company Buys Sells Direction
MultiPlan Corp CTEV 10 0 Net buying

Activity

March 2026
2026-03-16 Claritev Corp CTEV
high
Buy
1,300 shares
$22,997
Significance 7/10

EVP&CFO Garis Douglas Michael bought 1,300 shares of CTEV at $17.69; 5 of 5 prior buys at this ticker well-timed at 90-day mark, yet stock down 75.8% from 52-week high.

Garis Douglas Michael's purchase of 1,300 shares at $17.69 follows a striking pattern: his prior 5 open-market buys at Claritev all delivered positive 90-day returns (ranging from +84.6% to +158.8%), indicating consistent skill in entry timing at this specific ticker. His cross-ticker track record is similarly impressive, with 8 prior buys averaging +789.9% over 90 days and a 100.00% win rate. However, context demands caution: the stock is now -75.8% from its 52-week high and -23.4% in just 30 days, Claritev reported net income of $-69.8M on revenue of $246.0M, and the company remains unprofitable on a full-year basis. This buy occurs within a 14-day cluster involving 2 other insiders, suggesting coordinated action, yet the fundamental backdrop—steep price decline, operating losses, and severely depressed valuation (P/E of 0.29)—makes this transaction a test of whether prior timing success extends into a deteriorating business environment.

May 2025
2025-05-20 Claritev Corp CTEV
high
Buy
3,600 shares
$99,828
Significance 6/10

CFO Garis Douglas Michael bought 3,600 shares at $27.73 amid cluster buy pattern; CTEV stock at 52-week high but company unprofitable with -3.2% revenue decline.

EVP&CFO Garis Douglas Michael purchased 3,600 shares at $27.73 on 2025-05-19, increasing holdings to 143,861 shares (+2.6% net change). The transaction occurred while the stock trades at its 52-week high of $28.72 and has surged +43.0% over the past 30 days. However, this buy emerges against unfavorable fundamentals: the company posted net income of $-71,319,000 in the latest quarter, annual revenue contracted -3.2% year-over-year, and the company was unprofitable over its most recent full fiscal year. The transaction is part of a cluster pattern with 3 other insiders also buying within the past 14 days. At Claritev specifically, prior trades show mixed near-term results (ranging from -5.1% to +2.0% at 30 days), with measurable outcomes still pending on the most recent buys from May 12.

2025-05-13 Claritev Corp CTEV
medium
Buy
28,749 shares
$632,235
Significance 5/10

CFO Garis Douglas Michael bought 28,749 shares at blended avg $21.99 on 2025-05-12 ($632,234.75)

Garis Douglas Michael, EVP&CFO at Claritev Corp, executed 2 separate purchases totaling 28,749 shares for $632,234.75 on 2025-05-12 at a blended average price of $21.99. The current market price of $25.03 is near the 52-week high, and the stock has appreciated 23.2% over the past 30 days. However, the company's financial fundamentals are challenged: it reported a net loss of $-71,319,000.00 in the most recent quarter, operates with an unprofitable full fiscal year, and shows annual revenue declining 3.2% year-over-year. At the same ticker, his 3 prior trades in early March 2025 generated mixed 30-day returns of +2.0%, -5.1%, and -3.8%, showing no clear pattern of well-timed accumulation at CTEV. While his cross-ticker track record shows an exceptional 90-day average return of +2790.8% with a 100.00% win rate across 5 prior buys, that performance does not yet extend to this stock, where recent open-market purchases have underperformed against the subsequent price movement.

March 2025
2025-03-10 Claritev Corp CTEV
medium
Buy
8,919 shares
$175,891
Significance 5/10

CFO Garis Douglas Michael purchased 8,919 shares for $175,890.96 across 3 transactions on 2025-03-07, post-IPO buy at blended average $19.72.

Garis Douglas Michael, EVP and CFO, executed three separate open-market purchases totaling 8,919 shares for $175,890.96 on 2025-03-07, with a blended average price of $19.72. The transaction occurred just 7 trading days after the company's recent IPO listing, suggesting opportunistic accumulation in the immediate post-listing window. The current price of $17.35 reflects a 12.1% decline from the blended transaction price, indicating the insider entered above current valuations. Given that Claritev reported a net loss of $-391,450,000.00 in its latest period and annual revenue contraction of -3.2% despite $230,495,000.00 in quarterly revenue, the company faces significant profitability headwinds that may weigh on post-IPO momentum.

August 2024
2024-08-07 MultiPlan Corp CTEV
high
Buy
1,150,000 shares
$345,755
Significance 6/10

CFO Garis Douglas Michael bought 1,150,000 shares at blended $0.30 on 2024-08-06; part of cluster with 2 other insiders in past 14 days.

Garis Douglas Michael (EVP, CFO & Treasurer) executed 2 separate purchases totaling 1,150,000 shares for $345,755.00 on 2024-08-06, increasing his holdings by 32.2% from 3,571,428 to 4,721,428 shares. This filing is noteworthy because it occurred as part of a cluster pattern—2 other insiders also bought within the past 14 days—which suggests coordinated insider accumulation at a moment when MultiPlan's stock trades at $11.28, down 86.6% from its 52-week high of $84.40 and declining 60.9% over the past 90 days. The company reported a net loss of $576,727,000.00 in its latest quarter, annual revenue declined 11.0% year-over-year, and the company was unprofitable over its most recent full fiscal year. The magnitude of the CFO's share increase combined with the unprofitable and declining business backdrop creates tension worth monitoring: insiders are accumulating equity positions at distressed valuations while fundamental performance has deteriorated sharply.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access